Pharma Market Rebounds in September 1st Time Since Covid-19
For the first time since the pandemic, the domestic pharma retail industry bounced back, recording a rise of over 4% in September, helped by improved sales of chronic drugs and anti-virals used to treat coronavirus. This stems from the optimistic developments in macro-economic indicators, boosting expectations that the economy will pick up.